Abrocitinib: A Comprehensive Review of its Efficacy and Safety in Dermatology
Abrocitinib is a novel oral small molecule which acts as a selective JAK-1 inhibitor. Currently approved for use in moderate-to-severe cases of atopic dermatitis, this drug is gaining a rapid impetus for its use across various inflammatory dermatoses for its selective downstream action on cytokines...
I tiakina i:
| Ngā kaituhi matua: | , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
Wolters Kluwer Medknow Publications
2024-10-01
|
| Rangatū: | Indian Dermatology Online Journal |
| Ngā marau: | |
| Urunga tuihono: | https://journals.lww.com/10.4103/idoj.idoj_449_24 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|